Products
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceHiro for Analytics
Synapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
2026 R&D Benchmark Report
Glossary
Free tools
NEWWebinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
No credit card required
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Complement inhibition and SGLT2 approaches are reshaping IgAN and FSGS treatment. Explore the patent landscape, key targets, and emerging combination strategies.
Article | Report What is V2G technology and what engineering barriers block mass deployment? Patent evidence reveals utilisation rates below 30% and 25-minute mobile dispatch delays.
Article | Report AUV patent landscape 2026: deep reinforcement learning, swarm coordination, and cross-domain systems are reshaping underwater robotics. See who's filing and where.
Article | Report How NVIDIA's NVLink-C2C die-to-die interconnect eliminates PCIe latency penalties in multi-chip GPU modules like Grace Hopper — patent analysis and benchmarks.
Article | Report ARID1A is mutated in up to 50% of ovarian clear-cell carcinomas. Discover how SMARCA4, SMARCA2, PROTACs, and EZH2 inhibitors are reshaping the SWI/SNF cancer therapy landscape.
Article | Report OCT patent landscape 2026: AI integration, robotic surgical guidance, and home-use devices are reshaping optical coherence tomography innovation. Full analysis inside.
Article | Report OCT patent landscape 2026: AI integration, robotic surgical guidance, and home-use devices are reshaping optical coherence tomography innovation. Explore the full analysis.
Article | Report How to reduce power leakage in SRAM cache at sub-3nm nodes: threshold voltage engineering, body biasing, power gating, and PVT-adaptive techniques from 50+ patents.
Article | Report How to reduce power leakage in SRAM cache at sub-3nm nodes: threshold voltage engineering, body biasing, power gating, and PVT-adaptive voltage scaling explained.
Article | Report Analyse the cardiorenal drug pipeline in DKD and HFpEF: MRA vs. SGLT2 inhibitor patent strategies, combination approaches, and emerging targets like HDAC6 and CYP11B2.
Article | Report How to reduce SRAM cache power leakage at sub-3nm nodes: threshold voltage engineering, body biasing, power gating, and PVT-adaptive voltage scaling explained.
Article | Report Mapping the 2026 AI drug discovery patent landscape: generative molecular design, DTI prediction, drug repurposing, and clinical AI—across 60+ records from 2017–2026.
Article | Report How optical neural networks use photonic chips to cut AI training energy costs. Patent landscape analysis covering MIT, Tsinghua, ARM, and 60+ filings (2017–2025).
Article | Report Ultra-wide bandgap semiconductors (Ga₂O₃, AlN, diamond) are redefining power electronics and deep-UV photonics. Explore the 2026 patent landscape and key IP signals.
Article | Report ASOs, gene therapy, and small molecules in the DMD drug pipeline: patent landscape, key assignees, and emerging modalities from exon-skipping to AAV microdystrophin.